Biomarin Pharmaceutical Inc (BMRN)
Pretax margin
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | 679,272 | 840,037 | 674,305 | 541,763 | 391,451 | 298,679 | 237,353 | 188,563 | 151,678 | 108,105 | 72,146 | 149,576 | 100,560 | 56,304 | 35,609 | -75,350 | -48,961 | -64,017 | -120,446 | -42,322 |
| Revenue (ttm) | US$ in thousands | 3,094,001 | 3,063,608 | 2,950,227 | 2,853,915 | 2,752,809 | 2,588,398 | 2,471,644 | 2,419,226 | 2,310,557 | 2,234,572 | 2,173,095 | 2,096,039 | 2,008,311 | 1,911,709 | 1,879,604 | 1,846,275 | 1,848,588 | 1,916,630 | 1,844,422 | 1,860,435 |
| Pretax margin | 21.95% | 27.42% | 22.86% | 18.98% | 14.22% | 11.54% | 9.60% | 7.79% | 6.56% | 4.84% | 3.32% | 7.14% | 5.01% | 2.95% | 1.89% | -4.08% | -2.65% | -3.34% | -6.53% | -2.27% |
September 30, 2025 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $679,272K ÷ $3,094,001K
= 21.95%
Peer comparison
Sep 30, 2025
Company name
Symbol
Pretax margin
Biomarin Pharmaceutical Inc
BMRN
21.95%
Arrowhead Pharmaceuticals Inc
ARWR
6.62%
Regeneron Pharmaceuticals Inc
REGN
36.11%